Metabolic disorders can activate renin-angiotensin-aldosterone system (RAAS), increase angiotensin II and aldosterone activity, which leads to cardiomyocyte hypertrophy, increased cardiac fibroblast proliferation and myocardial remodeling acceleration (32, 34). This evidence concerns the gene REN and Other metabolic disease.